研发体系建设
Search documents
敷尔佳:目前已在哈尔滨、上海两地布局研发中心,构建了具备区域协同能力的研发体系
Mei Ri Jing Ji Xin Wen· 2025-09-24 07:34
Core Viewpoint - The company is focusing on enhancing its research and development capabilities by leveraging talent from Harbin Institute of Technology and expanding its R&D teams in multiple locations [1] Group 1: R&D Strategy - The company has established R&D centers in Harbin and Shanghai, creating a collaborative research system [1] - The current scale of the R&D team is steadily expanding, with ongoing efforts to build a core technical talent pipeline [1] - Future plans include increasing the recruitment and training of high-end R&D talent to improve team expertise and innovation capabilities [1] Group 2: Development Goals - The company aims to strengthen its core R&D capabilities to support technological breakthroughs and product iterations [1] - Suggestions from investors will be considered in the company's development strategy to promote high-quality growth of the R&D system [1]
时代电气绩后涨超4% 中期归母净利同比增长12.93% 公司目前已建立完善研发体系
Zhi Tong Cai Jing· 2025-08-25 02:27
Core Viewpoint - Times Electric (03898) reported a significant increase in revenue and net profit for the first half of 2025, leading to a stock price rise of over 4% following the earnings announcement [1] Financial Performance - The company achieved an operating revenue of approximately 12.214 billion yuan, representing a year-on-year growth of 17.95% [1] - The net profit attributable to shareholders was around 1.6715 billion yuan, with a year-on-year increase of 12.93% [1] - Basic earnings per share were reported at 1.21 yuan, and the company declared a cash dividend of 4.40 yuan per 10 shares (tax included) [1] Business Strategy and Innovation - The company focuses on the rail transit traction and conversion system sector, showcasing strong technological innovation capabilities [1] - It follows a "cohesive diversification" strategy to extend its technology into related fields [1] - A comprehensive R&D system has been established, enabling continuous innovation in product design, manufacturing, and testing [1] Research and Development Capabilities - The company has formed a technical committee to support decision-making in scientific and technological work [1] - It has adopted management systems and concepts such as CMMI and IPD, creating a collaborative R&D operation model for industry product application technology and innovative frontier technology [1] - The company possesses robust research and testing capabilities, with over 20 laboratories covering various business areas for research experiments, type tests, and factory tests [1]
港股异动 | 时代电气(03898)绩后涨超4% 中期归母净利同比增长12.93% 公司目前已建立完善研发体系
智通财经网· 2025-08-25 02:24
Core Viewpoint - Times Electric (03898) experienced a stock price increase of over 4% following the announcement of its mid-year results for 2025, reflecting positive financial performance and growth in revenue and net profit [1] Financial Performance - The company reported a revenue of approximately 12.214 billion yuan, representing a year-on-year growth of 17.95% [1] - The net profit attributable to shareholders was about 1.6715 billion yuan, showing a year-on-year increase of 12.93% [1] - Basic earnings per share were 1.21 yuan, with a cash dividend of 4.40 yuan per 10 shares (tax included) [1] Business Strategy and Innovation - Times Electric focuses on the rail transit traction and conversion system sector, demonstrating strong technological innovation capabilities [1] - The company follows a "cohesive diversification" strategy to extend its technology into related fields [1] - A comprehensive R&D system has been established, enabling continuous innovation in product design, manufacturing, and testing [1] Research and Development Capabilities - The company has formed a technical committee to support decision-making in scientific and technological work [1] - Management systems and concepts such as CMMI and IPD have been introduced to create a collaborative R&D operation model [1] - The company possesses robust research and testing capabilities, with over 20 laboratories covering various business areas for research experiments, type tests, and factory tests [1]
科伦药业:公司将通过产业创新升级保持输液领域的领先地位
Zheng Quan Ri Bao Zhi Sheng· 2025-08-12 11:40
Group 1 - The company aims to maintain its leading position in the infusion field through continuous industrial innovation and product structure adjustment [1] - The company is constructing a "dual-driven" development system focusing on antibiotic intermediates and synthetic biology to enhance its global competitiveness in the bioprocessing sector [1] - The establishment of a robust R&D system and diversified technological innovations will serve as the ultimate driving force for the company's long-term sustainability [1]
屹唐股份: 关于调整部分高级管理人员、核心技术人员的公告
Zheng Quan Zhi Xing· 2025-07-25 16:37
Core Points - The company has made adjustments to its senior management structure, specifically regarding the positions of Subhash Deshmukh and Schubert S. Chu, who will no longer serve as Vice Presidents but will continue their roles at the wholly-owned subsidiary, Mattson Technology, Inc. [1][3] - Schubert S. Chu is no longer recognized as a core technical personnel due to his position adjustment, but he remains employed at Mattson Technology, Inc. [2][3] - The company has added Fan Qiang as a new core technical personnel, recognizing his future contributions to core technology research and business development [3][4] - The adjustments in core technical personnel are part of the company's normal personnel structure optimization and will not adversely affect the company's core technology, patent ownership, or ongoing operations [5][6] Management and Technical Personnel Adjustments - The company has a total of three core technical personnel after the adjustments, which include Hao Allen Lu, Fan Qiang, and Lee Fook Hong [4] - The company emphasizes its commitment to research and development, having established a complete R&D system and a collaborative innovation team [4][5] - The adjustments are expected to facilitate the orderly and efficient advancement of various R&D projects and support future upgrades of core products [5][6] Company Operations and Future Outlook - The company continues to prioritize new technology and product innovation, viewing R&D as essential for maintaining competitive advantage in the global semiconductor market [5][6] - The company plans to increase R&D investment and enhance its R&D team to continuously improve its technological innovation capabilities [5][6]